Clarus Ventures

Entry	Author	Date	Location
Sientra Secures $65,000,000 Series C Round	VentureDeal	03/29/12	San Diego
Shire Shells Out $100M to Buy Ferrokin Biosciences	Luke Timmerman	03/15/12	San Francisco
Clarus Ventures Adjusts to Unpredictable Biotech World	Luke Timmerman	01/20/12	Boston
San Diego Life Sciences Roundup: Isis, Elevation, Proacta, and More	Bruce V. Bigelow	01/06/12	San Diego
Catabasis Pharmaceuticals Garners $8,000,000 Series A Round	VentureDeal	12/13/11	Boston
Momenta Gets a Steal on Promising Scientific Asset from Once-Hot Virdante	Arlene Weintraub	12/07/11	Boston
Best Buy Picks Up MindShift, Termeer Funds NanoString, Basho Adds $5M More, & More Boston-Area Deals News	Erin Kutz	11/09/11	Boston
NanoString Grabs $20M From GE, Former Genzyme CEO to Pursue Molecular Diagnostics	Luke Timmerman	11/07/11	Seattle
NanoString Technologies Obtains $20,000,000 Series D Funding	VentureDeal	11/07/11	Seattle
Catabasis Begins Human Trials of Omega-3-Inspired Diabetes Treatment	Arlene Weintraub	10/20/11	Boston
Cleave Biosciences Nabs $42M, Veteran Execs, to Chase Personalized Cancer Therapies	Luke Timmerman	10/11/11	San Francisco
Cleave Biosciences Receives $42,000,000 Series A Financing Round	VentureDeal	10/11/11	San Francisco
$41M for Restoration Robotics’ Hair Transplant Robot	Wade Roush	08/04/11	San Francisco
Restoration Robotics Lands $41,000,000 Series C Financing	VentureDeal	08/03/11	San Francisco
SARCode Secures $44,000,000 Series B Round	VentureDeal	07/18/11	San Francisco
Allozyne Acquires Poniard Pharmaceuticals, Finds Backdoor Route to NASDAQ	Luke Timmerman	06/22/11	Seattle
VBI Progressing with Vaccines That Don’t Require Refrigeration	Ryan McBride	03/24/11	Boston
Alexion Pharma Gobbles Up Taligen in $111M Buyout	Ryan McBride	01/31/11	Boston
Pearl Therapeutics, Fresh Off Big VC Round, Tops $3B Lung Drug in Head-to-Head Trial	Luke Timmerman	12/01/10	San Francisco
Exelixis Seeks to Exit Doghouse, Sangamo Morphs Into Drugmaker, Siluria Adds $13M, & More Bay Area Life Sciences News	Luke Timmerman	10/22/10	San Francisco
Pearl Therapeutics Gets $69M	Luke Timmerman	10/19/10	San Francisco
Pearl Therapeutics Receives $69,000,000 Series C Financing Round	VentureDeal	10/19/10	San Francisco
Lycera CEO Resigns After Less Than One Year, Michigan Startup Plans to Keep Boston Presence	Luke Timmerman	09/17/10	Detroit
Anchor Sinks $10M Series B, Aileron Lands Deal with Roche, C Change Launches Fund With Vanterra, & More Boston-Area Deals News	Erin Kutz	08/25/10	Boston
Taligen Collects $10M For Focus on Rare Diseases	Ryan McBride	08/23/10	Boston
Achillion Pharma Finds $50.1M	Ryan McBride	08/18/10	Boston
Cypress Bio Gets Buyout Offer, Trius Prepares for IPO, Arena Gains Following Vivus Setback, & More San Diego Life Sciences News	Bruce V. Bigelow	07/22/10	San Diego
Glaxo’s Tempero Pharma Advances on Hot Niche of Immunology	Ryan McBride	07/15/10	Boston
Zogenix Secures $50,000,000 New Financing	VentureDeal	07/14/10	San Diego
NanoString Hires Genzyme Vet as CEO to Lead Foray Into Molecular Diagnostics	Luke Timmerman	06/29/10	Seattle
Page 1 of 3	next page »

Entry

Author

Date

Location

Sientra Secures $65,000,000 Series C Round

VentureDeal

03/29/12

San Diego

Shire Shells Out $100M to Buy Ferrokin Biosciences

Luke Timmerman

03/15/12

San Francisco